1. Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China
    Xin Xu et al, 2016, Journal of the American Society of Nephrology CrossRef
  2. Membranous nephropathy: Clinical and immunological aspects
    Israel Nieto-Gañán et al, 2023, Translational Autoimmunity CrossRef
  3. Revisiting immunological and clinical aspects of membranous nephropathy
    Israel Nieto-Gañán et al, 2022, Clinical Immunology CrossRef
  4. Immunopathogenesis of membranous nephropathy: an update
    Hanna Debiec et al, 2014, Seminars in Immunopathology CrossRef
  5. The effect of coagulation factors polymorphisms on abortion
    Narjes Feizollahi et al, 2018, Frontiers in Biology CrossRef
  6. Association between PAI-1 Polymorphisms and Ischemic Stroke in a South Korean Case-Control Cohort
    Gun Ho Choi et al, 2023, International Journal of Molecular Sciences CrossRef
  7. The Genetic and Environmental Factors of Primary Membranous Nephropathy: An Overview from China
    Xiao-dan Zhang et al, 2018, Kidney Diseases CrossRef
  8. The −675 4G/5GPAI-1polymorphism confers genetic susceptibility to systemic lupus erythematosus, its clinical manifestations, and comorbidities in Mexican-Mestizo population
    B. U. Anaya-Macias et al, 2020, Autoimmunity CrossRef
  9. Membranous nephropathy: A review on the pathogenesis, diagnosis, and treatment
    Wei Ling Lai et al, 2015, Journal of the Formosan Medical Association CrossRef

  10. Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study


    Aly A Yousef et al, 2020, Journal of Inflammation Research CrossRef
  11. Elevated expression of plasminogen activator inhibitor (PAI-1/SERPINE1) is independent from rs1799889 genotypes in arthrofibrosis
    Banu Bayram et al, 2021, Meta Gene CrossRef